Detection Theileria spp by real time PCR
Bovine theileriosis caused by
T. annulata and
T. orientalis are transmitted by ixodid ticks that significantly affects animal productivity. On eastern coast of India, the hot and humid climatic condition encourage vector multiplication and thereby results in higher incidence of such ailment. For effective control of bovine theileriosis, a rapid, sensitive and specific diagnostic method is required. Multiplex qPCR has proven to be an effective approach for detecting and quantifying parasites
(Perera et al., 2015). Using a variety of molecular markers including major piroplasm surface protein (MPSP), 11 genotypes of
T. orientalis complex have been identified
(Gebrekidan et al. 2020).
Out of 55 samples, 42 (76.36%) samples were found positive for
Theileria spp, of which, 11 (26.11%) samples were positive to
Theileria annulata, 24 (57.14%) samples to
Theileria orientalis and 7 (16.66%) samples were positive for mixed infections. Rest 13 (23.63%) blood samples were tested negative for any of the
Theileria spp (Fig 1).
Concentration of Theileria orientalis in affected cattle
A standard linear curve was plotted taking ten-fold serial dilution of plasmid DNA for seven times with maximum (100 ng/µl or copy 10
10) and minimum (10 fg/µl or copy 10
3) concentrations of
T. orientalis. The concentration of haemoparasites in blood samples tested were deduced in clinically affected cows that ranged from 2.85×10
3 to 1.51×10
5 parasites per ml of blood. Parasitic load for
T. orientalis in clinically affected cases were measured against the above standard curve that ranged from 1.94×10
4 to 5.88×10
5 parasites per ml of blood (Fig 2 a and b). The prevalence study revealed the dominance of
T. orientalis over
T. annulata. The higher presence of
T. orientalis could be due to the possible role of the most abundant tick vector in India,
Rhipicephalus sp in transmission
(Patial et al., 2021). Parasitemia of
T. orientalis assessed through real time PCR in lactating cows of Odisha by RT PCR targeting MPSP gene from
T. orientalis cloned into pUC57 estimated the parasitic load to be ranging from 6.9-16.8×103/µl of blood
(Sahoo et al., 2020). Detection of
T. orientalis from
Haemaphyslis longicornis ticks using qPCR assay in South Australia reported genotypic concentration of different strains ranging from 3.5×10
1-3.6 x10
4 per ml of blood
(Hammer et al., 2016). The detection of
T. orientalis conducted by hydrolysis quantitative probe assay and quantified parasitemia (>3×10
5 GC/µl) showed strong correlation with clinical signs
(Boegma et al. 2015).
Efficacy of buparvaquone on Theileria spp.
In the 1980s, the development of new chemotherapeutic medicines like buparvaquone (BPQ) expanded therapy options. Due to its low toxicity and seven day plasma half-life, buparvaquone (BPQ) is the medicine of choice for treating theileriosis. However, point mutations in the parasite’s mitochondrial cytochrome b gene have resulted in resistance, which has become a source of concern
(Mhadhbi et al., 2015). Ten cows with clinical signs of fever (>104°F), anaemia, dyspnoea, salivation, swelling of pre-scapular lymph node, decreased milk yield and positive for
T. orientalis (through molecular test) were treated with buparvaquone (Butalex) @ 2.5 mg/kg bw at an interval of 48 hrs. The degree of parasitemia decreased 10 days post-treatment from 4.04×10
4 to 2.21×10
2 per ml of blood indicating significant reduction in parasitemia (Table 3). However, none of treated animal showed complete reduction of the
T. orientalis within such period as confirmed by and quantified by real time PCR for presence of
T. orientalis. While previous studies have documented efficacy of the drug against
T.annulata, the efficacy studies against
T.orientalis is scanty. Previous studies detected a significant drop in parasite DNA from 72.54+4.55% to 0.01+0.003%. during RT-PCR assay indicates its efficacy in treatment of
T. annulata with buparvaquone
(Dandsena et al., 2018). In the present investigation, reduction of the parasite load of
T. orientalis after treatment with two doses of buparvaquone at an interval of 48 hours indicates efficacy of the drug at the recommended dose and frequency. There has been previous reports of treatment of single dose of buparvaquone and repeat dose of buparvaqoune with oxytetracycline, where remission of clinical signs were observed
(Goud et al., 2020). The results of the study will help support the clinician to implement suitable therapeutic approach against prevailing theileriosis. Therapeutic trial on
T. annulata could not be included because of less number of positive cases. However, studies can be planned against mixed infection with
T. annulata.